162 related articles for article (PubMed ID: 36172139)
1. ADAMDEC1 accelerates GBM progression
Qi H; Wang P; Sun H; Li X; Hao X; Tian W; Yu L; Tang J; Dong J; Wang H
Front Oncol; 2022; 12():945025. PubMed ID: 36172139
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
Zhu W; Shi L; Gong Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
Thorac Cancer; 2022 Apr; 13(7):1027-1039. PubMed ID: 35178875
[TBL] [Abstract][Full Text] [Related]
3. Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation.
O'Shea NR; Chew TS; Dunne J; Marnane R; Nedjat-Shokouhi B; Smith PJ; Bloom SL; Smith AM; Segal AW
J Crohns Colitis; 2016 Dec; 10(12):1417-1427. PubMed ID: 27226416
[TBL] [Abstract][Full Text] [Related]
4. ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.
Lund J; Olsen OH; Sørensen ES; Stennicke HR; Petersen HH; Overgaard MT
J Biol Chem; 2013 Jul; 288(29):21367-21375. PubMed ID: 23754285
[TBL] [Abstract][Full Text] [Related]
5. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12.
Bates EE; Fridman WH; Mueller CG
Immunogenetics; 2002 May; 54(2):96-105. PubMed ID: 12037602
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro.
Liu X; Huang H; Li X; Zheng X; Zhou C; Xue B; He J; Zhang Y; Liu L
Histol Histopathol; 2020 Sep; 35(9):997-1005. PubMed ID: 32378728
[TBL] [Abstract][Full Text] [Related]
7. Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients.
Chai N; Xie P; Chen H; Li Y; Zhao Y; He J; Zhang H
Ann Transl Med; 2023 Jan; 11(1):14. PubMed ID: 36760254
[TBL] [Abstract][Full Text] [Related]
8. ADAM-like Decysin-1 (ADAMDEC1) is a positive regulator of Epithelial Defense Against Cancer (EDAC) that promotes apical extrusion of RasV12-transformed cells.
Yako Y; Hayashi T; Takeuchi Y; Ishibashi K; Kasai N; Sato N; Kuromiya K; Ishikawa S; Fujita Y
Sci Rep; 2018 Jun; 8(1):9639. PubMed ID: 29941981
[TBL] [Abstract][Full Text] [Related]
9. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
Xu J; Liu L; Zheng X; You C; Li Q
Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.
Lund J; Elimar Bitsch AM; Grønbech Rasch M; Enoksson M; Troeberg L; Nagase H; Loftager M; Overgaard MT; Petersen HH
MAbs; 2018 Jan; 10(1):118-128. PubMed ID: 29185848
[TBL] [Abstract][Full Text] [Related]
11. The role of ADAM-like decysin 1 in non-eosinophilic chronic rhinosinusitis with nasal polyps.
Sugimoto N; Nakayama T; Kasai Y; Asaka D; Mitsuyoshi R; Tsurumoto T; Takaishi S; Omae S; Kojima H; Tanaka Y; Haruna SI
Acta Otolaryngol; 2018 Sep; 138(9):830-836. PubMed ID: 29936897
[TBL] [Abstract][Full Text] [Related]
12. ADAMDEC1 promotes skin inflammation in rosacea via modulating the polarization of M1 macrophages.
Liu T; Deng Z; Xie H; Chen M; Xu S; Peng Q; Sha K; Xiao W; Zhao Z; Li J
Biochem Biophys Res Commun; 2020 Jan; 521(1):64-71. PubMed ID: 31627897
[TBL] [Abstract][Full Text] [Related]
13. Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα
Ha SE; Jorgensen BG; Wei L; Jin B; Kim MS; Poudrier SM; Singh R; Bartlett A; Zogg H; Kim S; Baek G; Kurahashi M; Lee MY; Kim YS; Choi SC; Sasse KC; Rubin SJS; Gottfried-Blackmore A; Becker L; Habtezion A; Sanders KM; Ro S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563399
[TBL] [Abstract][Full Text] [Related]
14. The roles of ADAMDEC1 in trophoblast differentiation during normal pregnancy and preeclampsia.
Li ZH; Li X; Li FF; Wu ZH; Xie YL; Zhang S; Chen XM; Wang YX; Ding YB; Liu TH
Mol Hum Reprod; 2022 Apr; 28(5):. PubMed ID: 35536241
[TBL] [Abstract][Full Text] [Related]
15. Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.
Lund J; Troeberg L; Kjeldal H; Olsen OH; Nagase H; Sørensen ES; Stennicke HR; Petersen HH; Overgaard MT
J Biol Chem; 2015 Mar; 290(10):6620-9. PubMed ID: 25564618
[TBL] [Abstract][Full Text] [Related]
16. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
[TBL] [Abstract][Full Text] [Related]
17. Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.
Shi L; Li S; Maurer K; Zhang Z; Petri M; Sullivan KE
Mol Immunol; 2018 Nov; 103():312-321. PubMed ID: 30352365
[TBL] [Abstract][Full Text] [Related]
18. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.
Jimenez-Pascual A; Hale JS; Kordowski A; Pugh J; Silver DJ; Bayik D; Roversi G; Alban TJ; Rao S; Chen R; McIntyre TM; Colombo G; Taraboletti G; Holmberg KO; Forsberg-Nilsson K; Lathia JD; Siebzehnrubl FA
Cancer Discov; 2019 Nov; 9(11):1574-1589. PubMed ID: 31434712
[TBL] [Abstract][Full Text] [Related]
19. ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells.
Jimenez-Pascual A; Lathia JD; Siebzehnrubl FA
Mol Cell Oncol; 2020; 7(1):1684787. PubMed ID: 31993498
[TBL] [Abstract][Full Text] [Related]
20. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
